NR4A1 and neoplasm: Consequently, this susceptible clone is effectively eradicated, while pre-existing or adaptively resistant hormone receptor-negative tumor cells, which may employ alternative survival pathways, persist, expand, and ultimately dominate the residual disease (13, 14).